StonvexLoading…
StonvexStonvexStonvexCore line items from ESCA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $240.16M | $251.51M | $263.57M | $313.76M |
Operating Income | $18.73M | $20.00M | $17.81M | $26.32M |
Net Income | $13.70M | $12.99M | $9.83M | $17.99M |
EPS (Diluted) | $0.99 | $0.93 | $0.71 | $1.31 |
Total Assets | $222.11M | $226.33M | $253.00M | $298.72M |
Total Liabilities | $48.89M | $57.33M | $88.43M | $140.24M |
Cash & Equivalents | $11.88M | $4.19M | $16.00K | $3.97M |
Free Cash Flow OCF − CapEx | $28.50M | $34.01M | $46.24M | $6.41M |
Shares Outstanding | 13.86M | 13.73M | 13.74M | 13.59M |